Crinetics Pharmaceuticals Inc’s recently made public that its Chief Med and Dev Officer Pizzuti Dana unloaded Company’s shares for reported $0.78 million on Jan 03 ’25. In the deal valued at $52.09 per share,15,000 shares were sold. As a result of this transaction, Pizzuti Dana now holds 29,248 shares worth roughly $1.19 million.
Then, DANA J PIZZUTI bought 15,000 shares, generating $781,323 in total proceeds.
Before that, Struthers Richard Scott sold 10,000 shares. Crinetics Pharmaceuticals Inc shares valued at $575,700 were divested by the President & CEO at a price of $57.57 per share. As a result of the transaction, Struthers Richard Scott now holds 100,000 shares, worth roughly $4.06 million.
Citigroup initiated its Crinetics Pharmaceuticals Inc [CRNX] rating to a Buy in a research note published on March 06, 2024; the price target was $68. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid January with a ‘”an Overweight”‘ rating. Jefferies began covering CRNX with “Hold” recommendation on December 21, 2023.
Price Performance Review of CRNX
On Friday, Crinetics Pharmaceuticals Inc [NASDAQ:CRNX] saw its stock fall -16.31% to $40.59. Over the last five days, the stock has lost -21.26%. Crinetics Pharmaceuticals Inc shares have fallen nearly -20.61% since the year began. Nevertheless, the stocks have risen 7.04% over the past one year. While a 52-week high of $62.53 was reached on 01/03/25, a 52-week low of $35.24 was recorded on 01/10/25. SMA at 50 days reached $55.31, while 200 days put it at $51.10.
Levels Of Support And Resistance For CRNX Stock
The 24-hour chart illustrates a support level at 37.90, which if violated will result in even more drops to 35.21. On the upside, there is a resistance level at 45.42. A further resistance level may holdings at 50.25. The Relative Strength Index (RSI) on the 14-day chart is 22.69, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.94, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.27%. Stochastics %K at 5.54% indicates the stock is a buying.
How much short interest is there in Crinetics Pharmaceuticals Inc?
A steep rise in short interest was recorded in Crinetics Pharmaceuticals Inc stocks on 2024-12-13, dropping by -0.25 million shares to a total of 6.25 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 6.5 million shares. There was a decline of -3.99%, which implies that there is a negative sentiment for the stock.
